| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 | 1.28e-30 | 46 | 41 | 15 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 | 1.18e-20 | 188 | 41 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 AHNAK | 7.81e-12 | 891 | 41 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.75e-06 | 12 | 41 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 2.48e-06 | 192 | 41 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.68e-05 | 268 | 41 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 4.77e-05 | 323 | 41 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.45e-05 | 38 | 41 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.91e-05 | 118 | 41 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | collagen binding | 6.13e-04 | 81 | 41 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 9.75e-04 | 95 | 41 | 3 | GO:0048029 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.24e-03 | 230 | 41 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | D-mannose binding | 1.40e-03 | 27 | 41 | 2 | GO:0005537 | |
| GeneOntologyMolecularFunction | growth factor binding | 4.01e-03 | 156 | 41 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 5.97e-03 | 180 | 41 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 6.63e-03 | 187 | 41 | 3 | GO:0030414 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL4A3 COL6A1 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL19A1 COLQ COL28A1 | 1.59e-13 | 377 | 40 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL4A3 COL6A1 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL19A1 COLQ COL28A1 | 1.65e-13 | 378 | 40 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL4A3 COL6A1 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL19A1 COLQ COL28A1 | 1.71e-13 | 379 | 40 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | opsonization | 6.41e-06 | 19 | 40 | 3 | GO:0008228 | |
| GeneOntologyBiologicalProcess | multicellular organismal locomotion | 2.19e-05 | 4 | 40 | 2 | GO:0071965 | |
| GeneOntologyBiologicalProcess | response to muscle activity | 3.88e-05 | 34 | 40 | 3 | GO:0014850 | |
| GeneOntologyBiologicalProcess | cell recognition | 3.88e-05 | 198 | 40 | 5 | GO:0008037 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 7.36e-05 | 42 | 40 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | positive regulation of opsonization | 1.31e-04 | 9 | 40 | 2 | GO:1903028 | |
| GeneOntologyBiologicalProcess | regulation of opsonization | 1.99e-04 | 11 | 40 | 2 | GO:1903027 | |
| GeneOntologyBiologicalProcess | neuron fate determination | 1.99e-04 | 11 | 40 | 2 | GO:0048664 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 2.39e-04 | 12 | 40 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | complement activation, lectin pathway | 2.39e-04 | 12 | 40 | 2 | GO:0001867 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 3.79e-04 | 15 | 40 | 2 | GO:0030049 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 4.31e-04 | 76 | 40 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.50e-04 | 18 | 40 | 2 | GO:0038065 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 5.50e-04 | 18 | 40 | 2 | GO:0033275 | |
| GeneOntologyBiologicalProcess | response to activity | 7.06e-04 | 90 | 40 | 3 | GO:0014823 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A3 COL6A1 COLEC11 COL6A2 COL5A3 COL7A1 OTOL1 C1QTNF3 COL22A1 COLEC10 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 7.50e-38 | 88 | 41 | 20 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 1.66e-18 | 530 | 41 | 18 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 7.14e-17 | 656 | 41 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 7.53e-17 | 658 | 41 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 3.82e-14 | 332 | 41 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.48e-10 | 21 | 41 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane | 3.70e-09 | 122 | 41 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.90e-07 | 8 | 41 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.85e-06 | 16 | 41 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.56e-05 | 25 | 41 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.22e-05 | 28 | 41 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | collagen type V trimer | 2.25e-05 | 4 | 41 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.60e-05 | 6 | 41 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A1 COL4A3 COL6A1 MYH1 MYH2 COL5A3 MYH4 KIF18B COL28A1 AHNAK | 7.47e-05 | 1187 | 41 | 10 | GO:0099081 |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.04e-04 | 8 | 41 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.04e-04 | 8 | 41 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | myofibril | 1.87e-04 | 273 | 41 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | myosin complex | 2.11e-04 | 59 | 41 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.45e-04 | 12 | 41 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.45e-04 | 12 | 41 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.47e-04 | 290 | 41 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 6.97e-04 | 20 | 41 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 8.46e-04 | 22 | 41 | 2 | GO:1905286 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.81e-03 | 1179 | 41 | 8 | GO:0099512 | |
| GeneOntologyCellularComponent | A band | 4.68e-03 | 52 | 41 | 2 | GO:0031672 | |
| GeneOntologyCellularComponent | cell-cell junction | 5.74e-03 | 591 | 41 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | sarcolemma | 6.11e-03 | 190 | 41 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcomere | 1.28e-02 | 249 | 41 | 3 | GO:0030017 | |
| GeneOntologyCellularComponent | multivesicular body | 1.29e-02 | 88 | 41 | 2 | GO:0005771 | |
| HumanPheno | Facial palsy | 8.02e-08 | 232 | 15 | 8 | HP:0010628 | |
| HumanPheno | Abnormal seventh cranial physiology | 8.29e-08 | 233 | 15 | 8 | HP:0010827 | |
| HumanPheno | Abnormal morphology of the musculature of the neck | 2.18e-07 | 171 | 15 | 7 | HP:0011006 | |
| HumanPheno | Weakness of facial musculature | 2.54e-07 | 269 | 15 | 8 | HP:0030319 | |
| HumanPheno | Abnormality of facial soft tissue | COL4A1 COL4A3 COL6A1 MYH2 COL6A2 KMT2D COL13A1 COL25A1 COLQ FOXG1 | 2.93e-07 | 538 | 15 | 10 | HP:0011799 |
| HumanPheno | Cranial nerve paralysis | 1.20e-06 | 329 | 15 | 8 | HP:0006824 | |
| HumanPheno | Abnormal cranial nerve physiology | 1.29e-06 | 332 | 15 | 8 | HP:0031910 | |
| HumanPheno | Abnormality of facial musculature | 2.44e-06 | 361 | 15 | 8 | HP:0000301 | |
| HumanPheno | Abnormal cranial nerve morphology | 3.26e-06 | 375 | 15 | 8 | HP:0001291 | |
| HumanPheno | Hip dislocation | 4.07e-06 | 263 | 15 | 7 | HP:0002827 | |
| HumanPheno | Neck muscle weakness | 5.26e-06 | 95 | 15 | 5 | HP:0000467 | |
| HumanPheno | Abnormality of muscle size | COL4A1 COL6A1 COLEC11 COL6A2 COL7A1 COL13A1 COL25A1 COLQ FOXG1 RAI1 | 5.94e-06 | 740 | 15 | 10 | HP:0030236 |
| HumanPheno | Axial muscle weakness | 1.04e-05 | 50 | 15 | 4 | HP:0003327 | |
| HumanPheno | Abnormal axial muscle morphology | 1.21e-05 | 52 | 15 | 4 | HP:0040286 | |
| HumanPheno | Weakness of muscles of respiration | 1.41e-05 | 116 | 15 | 5 | HP:0004347 | |
| HumanPheno | Lower extremity joint dislocation | 1.44e-05 | 318 | 15 | 7 | HP:0030311 | |
| HumanPheno | Waddling gait | 2.45e-05 | 130 | 15 | 5 | HP:0002515 | |
| HumanPheno | Generalized muscle weakness | 2.84e-05 | 134 | 15 | 5 | HP:0003324 | |
| HumanPheno | Distal muscle weakness | 2.92e-05 | 354 | 15 | 7 | HP:0002460 | |
| HumanPheno | Decreased fetal movement | 3.11e-05 | 234 | 15 | 6 | HP:0001558 | |
| HumanPheno | Type 1 muscle fiber predominance | 3.15e-05 | 66 | 15 | 4 | HP:0003803 | |
| HumanPheno | Scoliosis | COL6A1 MYH2 COLEC11 COL6A2 KMT2D COLEC10 COL13A1 COL25A1 COLQ FOXG1 RAI1 | 3.19e-05 | 1122 | 15 | 11 | HP:0002650 |
| HumanPheno | Abnormality of upper limb joint | COL6A1 MYH2 COLEC11 COL6A2 COL7A1 COLEC10 COL13A1 COL25A1 COLQ | 4.06e-05 | 705 | 15 | 9 | HP:0009810 |
| HumanPheno | Prenatal movement abnormality | 4.13e-05 | 246 | 15 | 6 | HP:0001557 | |
| HumanPheno | Abnormality of the shoulder girdle musculature | 4.74e-05 | 149 | 15 | 5 | HP:0001435 | |
| HumanPheno | Reduced muscle collagen VI | 4.84e-05 | 4 | 15 | 2 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 4.84e-05 | 4 | 15 | 2 | HP:0010176 | |
| HumanPheno | Reduced maximal expiratory pressure | 4.84e-05 | 4 | 15 | 2 | HP:0012497 | |
| HumanPheno | Abnormality of skeletal muscles | 5.23e-05 | 727 | 15 | 9 | HP:0040290 | |
| HumanPheno | Joint dislocation | 5.48e-05 | 390 | 15 | 7 | HP:0001373 | |
| HumanPheno | Abnormal curvature of the vertebral column | COL6A1 MYH2 COLEC11 COL6A2 KMT2D COLEC10 COL13A1 COL25A1 COLQ FOXG1 RAI1 | 7.30e-05 | 1219 | 15 | 11 | HP:0010674 |
| HumanPheno | Abnormal muscle fiber-type distribution | 7.80e-05 | 83 | 15 | 4 | HP:0033684 | |
| HumanPheno | Increased laxity of fingers | 8.05e-05 | 5 | 15 | 2 | HP:0006149 | |
| HumanPheno | Skeletal muscle atrophy | 8.25e-05 | 579 | 15 | 8 | HP:0003202 | |
| HumanPheno | Abnormality of the wrist | 8.44e-05 | 168 | 15 | 5 | HP:0003019 | |
| HumanPheno | Limited elbow movement | 8.44e-05 | 168 | 15 | 5 | HP:0002996 | |
| HumanPheno | Abnormality of the elbow | 8.94e-05 | 282 | 15 | 6 | HP:0009811 | |
| HumanPheno | Torticollis | 9.39e-05 | 87 | 15 | 4 | HP:0000473 | |
| HumanPheno | Limitation of joint mobility | 1.06e-04 | 432 | 15 | 7 | HP:0001376 | |
| HumanPheno | Caudal appendage | 1.21e-04 | 6 | 15 | 2 | HP:0002825 | |
| HumanPheno | Prominent coccyx | 1.21e-04 | 6 | 15 | 2 | HP:0040016 | |
| HumanPheno | Abnormal fetal physiology | 1.46e-04 | 308 | 15 | 6 | HP:0034059 | |
| HumanPheno | Atrophic scars | 1.51e-04 | 37 | 15 | 3 | HP:0001075 | |
| HumanPheno | Scapular winging | 1.55e-04 | 99 | 15 | 4 | HP:0003691 | |
| HumanPheno | Areflexia | 1.63e-04 | 314 | 15 | 6 | HP:0001284 | |
| HumanPheno | Wrist flexion contracture | 1.64e-04 | 38 | 15 | 3 | HP:0001239 | |
| HumanPheno | Wrist hypermobility | 1.69e-04 | 7 | 15 | 2 | HP:0005072 | |
| HumanPheno | Respiratory insufficiency due to muscle weakness | 1.81e-04 | 103 | 15 | 4 | HP:0002747 | |
| HumanPheno | Muscle weakness | COL4A1 COL6A1 MYH2 COL6A2 KMT2D COL13A1 COL25A1 COLQ FOXG1 RAI1 | 1.84e-04 | 1079 | 15 | 10 | HP:0001324 |
| HumanPheno | Abnormality of the musculature of the limbs | 2.07e-04 | 658 | 15 | 8 | HP:0009127 | |
| HumanPheno | Abnormal joint physiology | COL6A1 MYH2 COLEC11 COL6A2 COL7A1 KMT2D COLEC10 COL13A1 COL25A1 COLQ RAI1 | 2.11e-04 | 1358 | 15 | 11 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL6A1 MYH2 COLEC11 COL6A2 COL7A1 KMT2D COLEC10 COL13A1 COL25A1 COLQ RAI1 | 2.11e-04 | 1358 | 15 | 11 | HP:0011729 |
| HumanPheno | Abnormal hip joint morphology | 2.36e-04 | 490 | 15 | 7 | HP:0001384 | |
| HumanPheno | Proximal muscle weakness | 2.53e-04 | 340 | 15 | 6 | HP:0003701 | |
| HumanPheno | Abnormal motor neuron morphology | 2.72e-04 | 501 | 15 | 7 | HP:0002450 | |
| HumanPheno | Abnormal peripheral nervous system morphology | COL4A1 COL6A1 MYH2 COL6A2 KMT2D TRANK1 COL13A1 COL25A1 COLQ FOXG1 RAI1 | 2.74e-04 | 1395 | 15 | 11 | HP:0000759 |
| HumanPheno | Abnormal synovial membrane morphology | 2.79e-04 | 503 | 15 | 7 | HP:0005262 | |
| HumanPheno | Increased variability in muscle fiber diameter | 2.87e-04 | 116 | 15 | 4 | HP:0003557 | |
| HumanPheno | Abnormal coccyx morphology | 2.88e-04 | 9 | 15 | 2 | HP:0008519 | |
| HumanPheno | Distal joint hypermobility | 2.88e-04 | 9 | 15 | 2 | HP:0020152 | |
| HumanPheno | Abnormal neuron morphology | 2.93e-04 | 507 | 15 | 7 | HP:0012757 | |
| HumanPheno | Hyperlordosis | 3.15e-04 | 222 | 15 | 5 | HP:0003307 | |
| HumanPheno | Lordosis | 3.15e-04 | 222 | 15 | 5 | HP:0002939 | |
| HumanPheno | Abnormality of skeletal muscle fiber size | 3.38e-04 | 121 | 15 | 4 | HP:0012084 | |
| HumanPheno | Limb muscle weakness | 3.41e-04 | 359 | 15 | 6 | HP:0003690 | |
| HumanPheno | Weak cry | 3.51e-04 | 49 | 15 | 3 | HP:0001612 | |
| HumanPheno | Cigarette-paper scars | 3.59e-04 | 10 | 15 | 2 | HP:0001073 | |
| HumanPheno | Craniofacial dystonia | 3.60e-04 | 123 | 15 | 4 | HP:0012179 | |
| HumanPheno | Limited pronation/supination of forearm | 4.38e-04 | 11 | 15 | 2 | HP:0006394 | |
| HumanPheno | Abnormal palate morphology | COL4A1 COL6A1 MYH2 COLEC11 COL6A2 KMT2D COLEC10 COL13A1 COLQ RAI1 | 4.74e-04 | 1202 | 15 | 10 | HP:0000174 |
| HumanPheno | Hypoventilation | 4.94e-04 | 55 | 15 | 3 | HP:0002791 | |
| HumanPheno | Abnormal shoulder morphology | 5.08e-04 | 246 | 15 | 5 | HP:0003043 | |
| HumanPheno | Ankle flexion contracture | 5.22e-04 | 56 | 15 | 3 | HP:0006466 | |
| HumanPheno | Pes valgus | 5.22e-04 | 56 | 15 | 3 | HP:0008081 | |
| HumanPheno | Ptosis | 5.43e-04 | 754 | 15 | 8 | HP:0000508 | |
| HumanPheno | Focal dystonia | 5.73e-04 | 139 | 15 | 4 | HP:0004373 | |
| HumanPheno | Abnormal neck morphology | 6.07e-04 | 766 | 15 | 8 | HP:0025668 | |
| HumanPheno | Spinal rigidity | 6.08e-04 | 59 | 15 | 3 | HP:0003306 | |
| HumanPheno | Marcus Gunn jaw winking synkinesis | 6.20e-04 | 13 | 15 | 2 | HP:0025186 | |
| HumanPheno | Large fleshy ears | 6.20e-04 | 13 | 15 | 2 | HP:0002265 | |
| HumanPheno | Ankle contracture | 6.39e-04 | 60 | 15 | 3 | HP:0034677 | |
| HumanPheno | Fetal anomaly | 6.42e-04 | 575 | 15 | 7 | HP:0034057 | |
| HumanPheno | Abnormal cry | 6.71e-04 | 61 | 15 | 3 | HP:0025429 | |
| HumanPheno | Abnormality of lower limb joint | COL6A1 COLEC11 COL6A2 COL7A1 KMT2D COLEC10 COL13A1 COL25A1 COLQ | 8.19e-04 | 1027 | 15 | 9 | HP:0100491 |
| HumanPheno | Muscle fiber necrosis | 8.31e-04 | 15 | 15 | 2 | HP:0003713 | |
| HumanPheno | Decreased size of nerve terminals | 8.31e-04 | 15 | 15 | 2 | HP:0003443 | |
| HumanPheno | Limited extraocular movements | 8.31e-04 | 15 | 15 | 2 | HP:0007941 | |
| HumanPheno | Epicanthus inversus | 8.31e-04 | 15 | 15 | 2 | HP:0000537 | |
| HumanPheno | Heterotropia | 9.36e-04 | 281 | 15 | 5 | HP:0032012 | |
| HumanPheno | Small joint hypermobilty | 9.63e-04 | 69 | 15 | 3 | HP:0430046 | |
| HumanPheno | Abnormality of the musculature of the upper limbs | 9.67e-04 | 283 | 15 | 5 | HP:0001446 | |
| HumanPheno | Reduced tendon reflexes | 9.90e-04 | 617 | 15 | 7 | HP:0001315 | |
| HumanPheno | Diaphragmatic weakness | 1.07e-03 | 17 | 15 | 2 | HP:0009113 | |
| HumanPheno | EMG abnormality | 1.13e-03 | 293 | 15 | 5 | HP:0003457 | |
| HumanPheno | Abnormality of mouth shape | 1.15e-03 | 294 | 15 | 5 | HP:0011338 | |
| HumanPheno | Atypical scarring of skin | 1.18e-03 | 74 | 15 | 3 | HP:0000987 | |
| HumanPheno | Slow pupillary light response | 1.21e-03 | 18 | 15 | 2 | HP:0030211 | |
| HumanPheno | Abnormal muscle fiber morphology | 1.30e-03 | 302 | 15 | 5 | HP:0004303 | |
| HumanPheno | Abnormality of the neck | 1.33e-03 | 858 | 15 | 8 | HP:0000464 | |
| HumanPheno | Abnormal hip bone morphology | 1.40e-03 | 653 | 15 | 7 | HP:0003272 | |
| MousePheno | myopathy | 1.19e-05 | 54 | 37 | 4 | MP:0000751 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 5.69e-05 | 80 | 37 | 4 | MP:0009404 | |
| MousePheno | muscle weakness | 1.26e-04 | 98 | 37 | 4 | MP:0000747 | |
| MousePheno | abnormal basement membrane morphology | 1.58e-04 | 40 | 37 | 3 | MP:0004272 | |
| MousePheno | abnormal skeletal muscle fiber type ratio | 1.58e-04 | 40 | 37 | 3 | MP:0009409 | |
| MousePheno | impaired skeletal muscle contractility | 2.10e-04 | 44 | 37 | 3 | MP:0002841 | |
| Domain | Collagen | COL4A1 COL4A3 COL6A1 COLEC11 COL6A2 COL5A3 COL7A1 OTOL1 C1QTNF3 COL22A1 COLEC10 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 3.25e-37 | 85 | 41 | 20 | PF01391 |
| Domain | Collagen | COL4A1 COL4A3 COL6A1 COLEC11 COL6A2 COL5A3 COL7A1 OTOL1 C1QTNF3 COL22A1 COLEC10 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD MARCO COL28A1 | 3.25e-37 | 85 | 41 | 20 | IPR008160 |
| Domain | TSPN | 1.29e-09 | 23 | 41 | 5 | SM00210 | |
| Domain | CTDL_fold | 1.17e-07 | 107 | 41 | 6 | IPR016187 | |
| Domain | VWA | 1.39e-07 | 56 | 41 | 5 | PF00092 | |
| Domain | Laminin_G | 1.67e-07 | 58 | 41 | 5 | IPR001791 | |
| Domain | - | 5.71e-07 | 74 | 41 | 5 | 3.40.50.410 | |
| Domain | VWFA | 9.54e-07 | 82 | 41 | 5 | PS50234 | |
| Domain | VWA | 1.08e-06 | 84 | 41 | 5 | SM00327 | |
| Domain | VWF_A | 2.43e-06 | 99 | 41 | 5 | IPR002035 | |
| Domain | Myosin_N | 4.39e-06 | 15 | 41 | 3 | IPR004009 | |
| Domain | Myosin_N | 4.39e-06 | 15 | 41 | 3 | PF02736 | |
| Domain | Myosin_tail_1 | 7.83e-06 | 18 | 41 | 3 | PF01576 | |
| Domain | Myosin_tail | 7.83e-06 | 18 | 41 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 9.28e-06 | 19 | 41 | 3 | IPR027401 | |
| Domain | - | 9.28e-06 | 19 | 41 | 3 | 4.10.270.10 | |
| Domain | - | 5.97e-05 | 97 | 41 | 4 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 6.47e-05 | 99 | 41 | 4 | IPR016186 | |
| Domain | C4 | 7.01e-05 | 6 | 41 | 2 | SM00111 | |
| Domain | - | 7.01e-05 | 6 | 41 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 7.01e-05 | 6 | 41 | 2 | IPR001442 | |
| Domain | NC1_IV | 7.01e-05 | 6 | 41 | 2 | PS51403 | |
| Domain | C4 | 7.01e-05 | 6 | 41 | 2 | PF01413 | |
| Domain | MYOSIN_MOTOR | 7.85e-05 | 38 | 41 | 3 | PS51456 | |
| Domain | Myosin_head | 7.85e-05 | 38 | 41 | 3 | PF00063 | |
| Domain | Myosin_head_motor_dom | 7.85e-05 | 38 | 41 | 3 | IPR001609 | |
| Domain | MYSc | 7.85e-05 | 38 | 41 | 3 | SM00242 | |
| Domain | ConA-like_dom | 1.13e-04 | 219 | 41 | 5 | IPR013320 | |
| Domain | C-type_lectin_CS | 1.14e-04 | 43 | 41 | 3 | IPR018378 | |
| Domain | IQ | 5.06e-04 | 71 | 41 | 3 | PF00612 | |
| Domain | - | 7.04e-04 | 18 | 41 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 7.04e-04 | 18 | 41 | 2 | IPR020901 | |
| Domain | C_TYPE_LECTIN_1 | 7.17e-04 | 80 | 41 | 3 | PS00615 | |
| Domain | IQ | 7.44e-04 | 81 | 41 | 3 | SM00015 | |
| Domain | BPTI_KUNITZ_2 | 7.85e-04 | 19 | 41 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 7.85e-04 | 19 | 41 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 7.85e-04 | 19 | 41 | 2 | PS00280 | |
| Domain | Lectin_C | 8.27e-04 | 84 | 41 | 3 | PF00059 | |
| Domain | CLECT | 8.27e-04 | 84 | 41 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 8.56e-04 | 85 | 41 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 8.85e-04 | 86 | 41 | 3 | IPR001304 | |
| Domain | IQ_motif_EF-hand-BS | 1.01e-03 | 90 | 41 | 3 | IPR000048 | |
| Domain | EPHD | 1.06e-03 | 22 | 41 | 2 | PS51805 | |
| Domain | IQ | 1.11e-03 | 93 | 41 | 3 | PS50096 | |
| Domain | Kunitz_BPTI | 1.16e-03 | 23 | 41 | 2 | IPR002223 | |
| Domain | - | 1.18e-03 | 95 | 41 | 3 | 2.60.120.200 | |
| Domain | C1Q | 2.24e-03 | 32 | 41 | 2 | SM00110 | |
| Domain | C1q | 2.24e-03 | 32 | 41 | 2 | PF00386 | |
| Domain | C1q_dom | 2.52e-03 | 34 | 41 | 2 | IPR001073 | |
| Domain | C1Q | 2.52e-03 | 34 | 41 | 2 | PS50871 | |
| Domain | LamG | 4.20e-03 | 44 | 41 | 2 | SM00282 | |
| Domain | - | 5.39e-03 | 50 | 41 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 7.19e-03 | 58 | 41 | 2 | IPR008983 | |
| Domain | PHD | 1.63e-02 | 89 | 41 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.70e-02 | 91 | 41 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.85e-02 | 95 | 41 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 1.88e-02 | 96 | 41 | 2 | PS01359 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 1.13e-25 | 41 | 34 | 13 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 3.33e-25 | 44 | 34 | 13 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 4.11e-23 | 61 | 34 | 13 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 1.58e-22 | 67 | 34 | 13 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 9.36e-22 | 76 | 34 | 13 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 9.88e-21 | 90 | 34 | 13 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 | 1.80e-18 | 64 | 34 | 11 | M26953 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL25A1 COL19A1 | 2.81e-17 | 53 | 34 | 10 | MM14566 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 2.74e-15 | 300 | 34 | 14 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 1.26e-14 | 258 | 34 | 13 | MM14572 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 | 1.47e-14 | 140 | 34 | 11 | M587 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL25A1 COL19A1 | 8.92e-14 | 114 | 34 | 10 | MM14571 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.15e-13 | 46 | 34 | 8 | M198 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.36e-12 | 74 | 34 | 8 | M160 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.93e-12 | 76 | 34 | 8 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.99e-11 | 85 | 34 | 8 | M16441 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.28e-11 | 50 | 34 | 7 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.78e-11 | 61 | 34 | 7 | M27103 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.09e-10 | 42 | 34 | 6 | M7169 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.07e-10 | 20 | 34 | 5 | MM15061 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.61e-09 | 63 | 34 | 6 | M11187 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.40e-08 | 76 | 34 | 6 | M27219 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.85e-08 | 38 | 34 | 5 | MM14969 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.30e-07 | 57 | 34 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.51e-07 | 58 | 34 | 5 | M2049 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.83e-07 | 66 | 34 | 5 | M18 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.26e-06 | 43 | 34 | 4 | M39565 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.72e-06 | 15 | 34 | 3 | M27161 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.21e-05 | 19 | 34 | 3 | M27221 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.75e-05 | 84 | 34 | 4 | M7098 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.98e-05 | 30 | 34 | 3 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.06e-05 | 32 | 34 | 3 | MM14924 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE | 8.42e-05 | 6 | 34 | 2 | M47785 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 1.18e-04 | 7 | 34 | 2 | MM14654 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 1.57e-04 | 8 | 34 | 2 | M47784 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 1.57e-04 | 8 | 34 | 2 | M27005 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.93e-04 | 47 | 34 | 3 | MM14925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN | 2.51e-04 | 10 | 34 | 2 | M47879 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.51e-04 | 10 | 34 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.51e-04 | 10 | 34 | 2 | MM1560 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 3.06e-04 | 11 | 34 | 2 | M47874 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.06e-04 | 11 | 34 | 2 | MM14926 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.06e-04 | 11 | 34 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.67e-04 | 12 | 34 | 2 | MM1526 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.75e-04 | 261 | 34 | 5 | MM15676 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.80e-04 | 59 | 34 | 3 | M27218 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 4.33e-04 | 13 | 34 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 4.33e-04 | 13 | 34 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.05e-04 | 14 | 34 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.05e-04 | 14 | 34 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.81e-04 | 15 | 34 | 2 | MM14922 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 6.28e-04 | 70 | 34 | 3 | M12294 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.43e-04 | 18 | 34 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.43e-04 | 18 | 34 | 2 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.04e-03 | 20 | 34 | 2 | M15394 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.28e-03 | 199 | 34 | 4 | M7253 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.38e-03 | 23 | 34 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.38e-03 | 23 | 34 | 2 | MM1427 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.67e-03 | 98 | 34 | 3 | M27152 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.28e-03 | 575 | 34 | 6 | M29853 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.06e-03 | 418 | 34 | 5 | MM15587 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.88e-03 | 132 | 34 | 3 | M11355 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.79e-03 | 43 | 34 | 2 | M53 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.65e-03 | 502 | 34 | 5 | MM14537 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 7.47e-03 | 54 | 34 | 2 | MM14655 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.45e-03 | 532 | 34 | 5 | M27870 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.63e-03 | 339 | 34 | 4 | M39736 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 9.16e-03 | 60 | 34 | 2 | MM14872 | |
| Pathway | WP_FOCAL_ADHESION | 1.02e-02 | 187 | 34 | 3 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.20e-02 | 199 | 34 | 3 | M39402 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 1.26e-02 | 71 | 34 | 2 | M1078 | |
| Pubmed | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 | 2.40e-19 | 153 | 41 | 12 | 25037231 | |
| Pubmed | COL4A1 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL16A1 COL25A1 COLQ SFTPD COL28A1 | 7.04e-19 | 167 | 41 | 12 | 22159717 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL16A1 COL28A1 | 5.60e-16 | 135 | 41 | 10 | 28675934 |
| Pubmed | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL15A1 COL16A1 COL28A1 | 7.86e-15 | 175 | 41 | 10 | 28071719 | |
| Pubmed | COL4A3 COL6A1 NCAM1 COL6A2 COL5A3 COL7A1 COL13A1 COL15A1 COL16A1 COL19A1 | 4.94e-14 | 210 | 41 | 10 | 16537572 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.19e-11 | 97 | 41 | 7 | 27559042 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.07e-10 | 62 | 41 | 6 | 28344315 | |
| Pubmed | 1.16e-10 | 8 | 41 | 4 | 26993635 | ||
| Pubmed | 9.88e-10 | 39 | 41 | 5 | 33580754 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.52e-09 | 3 | 41 | 3 | 26059207 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 10388558 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 6.08e-09 | 4 | 41 | 3 | 11029314 | |
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 11023856 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 6.08e-09 | 4 | 41 | 3 | 18417546 | |
| Pubmed | 1.28e-08 | 64 | 41 | 5 | 22261194 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.52e-08 | 5 | 41 | 3 | 30737693 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.52e-08 | 5 | 41 | 3 | 3829126 | |
| Pubmed | 1.52e-08 | 5 | 41 | 3 | 6196357 | ||
| Pubmed | Physical mapping of mouse collagen genes on chromosome 10 by high-resolution FISH. | 1.52e-08 | 5 | 41 | 3 | 11331940 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.52e-08 | 5 | 41 | 3 | 12919077 | |
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 20417199 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.03e-08 | 6 | 41 | 3 | 10077619 | |
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.03e-08 | 6 | 41 | 3 | 17559643 | |
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.03e-08 | 6 | 41 | 3 | 10588881 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 5.30e-08 | 7 | 41 | 3 | 9334230 | |
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 5.30e-08 | 7 | 41 | 3 | 29758057 | |
| Pubmed | 5.30e-08 | 7 | 41 | 3 | 16819597 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 8.48e-08 | 8 | 41 | 3 | 12766770 | |
| Pubmed | 8.48e-08 | 8 | 41 | 3 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 8.48e-08 | 8 | 41 | 3 | 14667415 | |
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 31960486 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.81e-07 | 10 | 41 | 3 | 15345741 | |
| Pubmed | 2.49e-07 | 11 | 41 | 3 | 18310078 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 2.49e-07 | 11 | 41 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 2.49e-07 | 11 | 41 | 3 | 29168801 | |
| Pubmed | 2.49e-07 | 11 | 41 | 3 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 2.49e-07 | 11 | 41 | 3 | 16024798 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 4.31e-07 | 13 | 41 | 3 | 8404542 | |
| Pubmed | 5.49e-07 | 14 | 41 | 3 | 24938781 | ||
| Pubmed | 5.49e-07 | 14 | 41 | 3 | 27184118 | ||
| Pubmed | 5.49e-07 | 14 | 41 | 3 | 33742095 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 6.85e-07 | 15 | 41 | 3 | 24852826 | |
| Pubmed | 8.07e-07 | 146 | 41 | 5 | 27068509 | ||
| Pubmed | 8.42e-07 | 16 | 41 | 3 | 16494860 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 8.42e-07 | 16 | 41 | 3 | 19922871 | |
| Pubmed | 8.42e-07 | 16 | 41 | 3 | 16880404 | ||
| Pubmed | Genetic loci that control vascular endothelial growth factor-induced angiogenesis. | 1.02e-06 | 17 | 41 | 3 | 12958152 | |
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.02e-06 | 17 | 41 | 3 | 22351927 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 1.23e-06 | 18 | 41 | 3 | 25753484 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.36e-06 | 2 | 41 | 2 | 22337492 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33982770 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.36e-06 | 2 | 41 | 2 | 9585413 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 27341702 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25710878 | ||
| Pubmed | Ullrich disease due to deficiency of collagen VI in the sarcolemma. | 1.36e-06 | 2 | 41 | 2 | 14981181 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30321347 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21102503 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30108587 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 6852033 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12374585 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25912189 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 16575183 | ||
| Pubmed | Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. | 1.36e-06 | 2 | 41 | 2 | 11865138 | |
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.36e-06 | 2 | 41 | 2 | 11551968 | |
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 1.36e-06 | 2 | 41 | 2 | 7545970 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 1765372 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28415608 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 2551668 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19309692 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.36e-06 | 2 | 41 | 2 | 11744674 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.36e-06 | 2 | 41 | 2 | 9382868 | |
| Pubmed | 1.99e-06 | 21 | 41 | 3 | 23325811 | ||
| Pubmed | 1.99e-06 | 21 | 41 | 3 | 27856617 | ||
| Pubmed | 2.31e-06 | 22 | 41 | 3 | 24301466 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.34e-06 | 79 | 41 | 4 | 18757743 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.29e-06 | 86 | 41 | 4 | 28327460 | |
| Pubmed | Directed differentiation of telencephalic precursors from embryonic stem cells. | 3.43e-06 | 25 | 41 | 3 | 15696161 | |
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 4.06e-06 | 3 | 41 | 2 | 25204870 | |
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 4.06e-06 | 3 | 41 | 2 | 19422682 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 3025878 | ||
| Pubmed | Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome. | 4.06e-06 | 3 | 41 | 2 | 32751929 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8168508 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 7780011 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 36515178 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20301676 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 4.06e-06 | 3 | 41 | 2 | 1371481 | |
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 4.06e-06 | 3 | 41 | 2 | 34049963 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23339872 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 4.06e-06 | 3 | 41 | 2 | 8782832 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 3904738 | ||
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 4.06e-06 | 3 | 41 | 2 | 12011280 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 21459131 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 36982625 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 4.06e-06 | 3 | 41 | 2 | 3198591 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12840783 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8145163 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 3665927 | ||
| Interaction | COLGALT2 interactions | COL4A1 COL6A1 COLEC11 COL6A2 C1QTNF3 COLEC10 COL13A1 COL16A1 COLQ | 9.14e-15 | 67 | 41 | 9 | int:COLGALT2 |
| Interaction | PLOD3 interactions | RALY COL4A1 COL6A1 COLEC11 COL6A2 COLEC10 COL13A1 COL16A1 COLQ MARCO AHNAK | 6.38e-14 | 183 | 41 | 11 | int:PLOD3 |
| Interaction | PLOD1 interactions | COL4A1 COL6A1 COL6A2 COL13A1 COL16A1 COL25A1 KIF18B COLQ AHNAK | 5.81e-09 | 292 | 41 | 9 | int:PLOD1 |
| Interaction | DCN interactions | 1.72e-06 | 43 | 41 | 4 | int:DCN | |
| Interaction | LAIR2 interactions | 2.92e-06 | 49 | 41 | 4 | int:LAIR2 | |
| Interaction | COLEC11 interactions | 7.40e-06 | 19 | 41 | 3 | int:COLEC11 | |
| Interaction | MMP9 interactions | 1.03e-05 | 67 | 41 | 4 | int:MMP9 | |
| Interaction | MMP2 interactions | 2.90e-05 | 87 | 41 | 4 | int:MMP2 | |
| Interaction | COL6A2 interactions | 3.32e-05 | 90 | 41 | 4 | int:COL6A2 | |
| Interaction | PDGFA interactions | 3.72e-05 | 32 | 41 | 3 | int:PDGFA | |
| Interaction | COLQ interactions | 4.09e-05 | 33 | 41 | 3 | int:COLQ | |
| Interaction | FN1 interactions | 4.13e-05 | 848 | 41 | 9 | int:FN1 | |
| Interaction | RSPH6A interactions | 4.48e-05 | 34 | 41 | 3 | int:RSPH6A | |
| Interaction | ASAH2 interactions | 6.03e-05 | 6 | 41 | 2 | int:ASAH2 | |
| Interaction | TLE3 interactions | 1.05e-04 | 376 | 41 | 6 | int:TLE3 | |
| Interaction | C1QTNF1 interactions | 1.19e-04 | 47 | 41 | 3 | int:C1QTNF1 | |
| Interaction | NID1 interactions | 1.27e-04 | 48 | 41 | 3 | int:NID1 | |
| Interaction | ACHE interactions | 2.63e-04 | 12 | 41 | 2 | int:ACHE | |
| Interaction | COL2A1 interactions | 2.99e-04 | 64 | 41 | 3 | int:COL2A1 | |
| Interaction | TMEM260 interactions | 3.11e-04 | 13 | 41 | 2 | int:TMEM260 | |
| Interaction | COL9A1 interactions | 3.11e-04 | 13 | 41 | 2 | int:COL9A1 | |
| Interaction | TSPAN33 interactions | 3.13e-04 | 65 | 41 | 3 | int:TSPAN33 | |
| Interaction | PRKAG2 interactions | 3.57e-04 | 68 | 41 | 3 | int:PRKAG2 | |
| Interaction | SLC39A3 interactions | 3.89e-04 | 70 | 41 | 3 | int:SLC39A3 | |
| Interaction | ACTN2 interactions | 3.97e-04 | 171 | 41 | 4 | int:ACTN2 | |
| Interaction | PLOD2 interactions | 4.82e-04 | 180 | 41 | 4 | int:PLOD2 | |
| Interaction | HABP2 interactions | 6.05e-04 | 18 | 41 | 2 | int:HABP2 | |
| Interaction | COL16A1 interactions | 6.05e-04 | 18 | 41 | 2 | int:COL16A1 | |
| Interaction | DEFB125 interactions | 7.50e-04 | 20 | 41 | 2 | int:DEFB125 | |
| Interaction | OSM interactions | 7.50e-04 | 20 | 41 | 2 | int:OSM | |
| Interaction | PDGFB interactions | 7.61e-04 | 88 | 41 | 3 | int:PDGFB | |
| Interaction | TIMP3 interactions | 8.12e-04 | 90 | 41 | 3 | int:TIMP3 | |
| Cytoband | 17p13.1 | 1.64e-04 | 118 | 41 | 3 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.66e-03 | 346 | 41 | 3 | chr17p13 | |
| Cytoband | 21q22.3 | 5.89e-03 | 128 | 41 | 2 | 21q22.3 | |
| GeneFamily | Collagens | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 2.58e-26 | 46 | 34 | 13 | 490 |
| GeneFamily | Collectins | 7.23e-07 | 10 | 34 | 3 | 491 | |
| GeneFamily | Myosin heavy chains | 2.72e-06 | 15 | 34 | 3 | 1098 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.17e-05 | 41 | 34 | 3 | 1298 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 5.15e-04 | 18 | 34 | 2 | 1372 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 1.42e-27 | 43 | 41 | 13 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COL28A1 | 2.01e-27 | 44 | 41 | 13 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 | 5.27e-20 | 270 | 41 | 15 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 OTOL1 COL22A1 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ COL28A1 | 6.96e-20 | 275 | 41 | 15 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL6A1 COLEC11 COL6A2 COL5A3 COL7A1 OTOL1 C1QTNF3 COL22A1 COLEC10 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD COL28A1 | 1.21e-16 | 1008 | 41 | 19 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL6A1 COLEC11 COL6A2 COL5A3 COL7A1 OTOL1 C1QTNF3 COL22A1 COLEC10 COL13A1 COL15A1 COL16A1 COL25A1 COL19A1 COLQ SFTPD COL28A1 | 1.67e-16 | 1026 | 41 | 19 | M5889 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.69e-11 | 40 | 41 | 6 | M5887 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 8.89e-09 | 97 | 41 | 6 | M45794 | |
| Coexpression | GU_PDEF_TARGETS_UP | 8.78e-08 | 71 | 41 | 5 | M3955 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 9.11e-08 | 369 | 41 | 8 | MM16610 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.80e-07 | 268 | 41 | 7 | M45796 | |
| Coexpression | HALLMARK_MYOGENESIS | 6.59e-07 | 200 | 41 | 6 | M5909 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 8.43e-07 | 337 | 41 | 7 | MM16606 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.38e-06 | 17 | 41 | 3 | M47995 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 3.30e-06 | 147 | 41 | 5 | M2387 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.98e-06 | 20 | 41 | 3 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 4.63e-06 | 21 | 41 | 3 | MM1102 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 4.70e-06 | 158 | 41 | 5 | MM934 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 6.16e-06 | 23 | 41 | 3 | M48001 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 8.28e-06 | 310 | 41 | 6 | MM16608 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.01e-05 | 27 | 41 | 3 | M47994 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.26e-05 | 29 | 41 | 3 | MM17055 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.42e-05 | 94 | 41 | 4 | M2580 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.47e-05 | 200 | 41 | 5 | M5930 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.48e-05 | 95 | 41 | 4 | MM1328 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 1.71e-05 | 32 | 41 | 3 | M308 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.88e-05 | 33 | 41 | 3 | M9167 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 2.04e-05 | 103 | 41 | 4 | M1170 | |
| Coexpression | CUI_TCF21_TARGETS_UP | 2.45e-05 | 36 | 41 | 3 | M7883 | |
| Coexpression | CUI_TCF21_TARGETS_UP | 2.66e-05 | 37 | 41 | 3 | MM1171 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 2.73e-05 | 111 | 41 | 4 | MM1111 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 2.83e-05 | 229 | 41 | 5 | MM16607 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.36e-05 | 117 | 41 | 4 | M39300 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.49e-05 | 126 | 41 | 4 | M39132 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 6.22e-05 | 137 | 41 | 4 | M40313 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.08e-05 | 681 | 41 | 7 | M39175 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 8.81e-05 | 55 | 41 | 3 | MM3666 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.08e-04 | 158 | 41 | 4 | MM17063 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.10e-04 | 493 | 41 | 6 | M19391 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.26e-04 | 505 | 41 | 6 | M39167 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.26e-04 | 62 | 41 | 3 | M16774 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.30e-04 | 11 | 41 | 2 | M47997 | |
| Coexpression | DESCARTES_MAIN_FETAL_STELLATE_CELLS | 1.32e-04 | 63 | 41 | 3 | M40119 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.33e-04 | 318 | 41 | 5 | M41707 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.43e-04 | 170 | 41 | 4 | M5880 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.45e-04 | 65 | 41 | 3 | M39309 | |
| Coexpression | SNF5_DN.V1_UP | 1.53e-04 | 173 | 41 | 4 | M2718 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.69e-04 | 767 | 41 | 7 | M39209 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 COL5A3 COL22A1 COL15A1 COL16A1 COL19A1 KIF18B COL28A1 | 1.95e-04 | 1054 | 41 | 8 | M45798 |
| Coexpression | ATF2_S_UP.V1_DN | 2.07e-04 | 187 | 41 | 4 | M2681 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.14e-04 | 352 | 41 | 5 | M17471 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 2.27e-04 | 563 | 41 | 6 | M15103 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.38e-04 | 194 | 41 | 4 | M39122 | |
| Coexpression | GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 2.62e-04 | 199 | 41 | 4 | M8538 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP | 2.62e-04 | 199 | 41 | 4 | M8848 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 2.67e-04 | 200 | 41 | 4 | M6485 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M8203 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 2.83e-04 | 16 | 41 | 2 | M5718 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 3.04e-04 | 380 | 41 | 5 | M45714 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.20e-04 | 17 | 41 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.20e-04 | 17 | 41 | 2 | MM1297 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 3.67e-04 | 89 | 41 | 3 | M40280 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 4.45e-04 | 95 | 41 | 3 | M1111 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 4.46e-04 | 20 | 41 | 2 | MM17053 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 4.92e-04 | 235 | 41 | 4 | M5311 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 4.92e-04 | 21 | 41 | 2 | MM1196 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_DN | 5.32e-04 | 101 | 41 | 3 | M1514 | |
| Coexpression | MURATA_VIRULENCE_OF_H_PILORI | 5.41e-04 | 22 | 41 | 2 | M18608 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 5.41e-04 | 22 | 41 | 2 | M1627 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 5.64e-04 | 103 | 41 | 3 | MM476 | |
| Coexpression | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP | 6.45e-04 | 24 | 41 | 2 | M18292 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 7.00e-04 | 25 | 41 | 2 | M47986 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 7.61e-04 | 465 | 41 | 5 | M9192 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 7.93e-04 | 267 | 41 | 4 | M12890 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 8.17e-04 | 117 | 41 | 3 | M45663 | |
| Coexpression | LI_WILMS_TUMOR | 8.17e-04 | 27 | 41 | 2 | M10773 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 1.01e-03 | 30 | 41 | 2 | M47990 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.06e-03 | 289 | 41 | 4 | M41750 | |
| Coexpression | RB_P107_DN.V1_UP | 1.11e-03 | 130 | 41 | 3 | M2802 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 1.15e-03 | 32 | 41 | 2 | MM657 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.22e-03 | 300 | 41 | 4 | M45675 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 1.22e-03 | 33 | 41 | 2 | M7409 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.22e-03 | 33 | 41 | 2 | M1904 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.37e-03 | 35 | 41 | 2 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.37e-03 | 35 | 41 | 2 | M11788 | |
| Coexpression | MEL18_DN.V1_UP | 1.40e-03 | 141 | 41 | 3 | M2784 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.45e-03 | 36 | 41 | 2 | MM1212 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.49e-03 | 144 | 41 | 3 | M1484 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 1.52e-03 | 145 | 41 | 3 | M2779 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.54e-03 | 37 | 41 | 2 | MM1258 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | COL6A1 MYH1 MYH2 COLEC11 C1QTNF3 COLEC10 COL15A1 COL16A1 COL25A1 COL19A1 AHNAK INKA2 | 9.14e-09 | 761 | 40 | 12 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.13e-07 | 229 | 40 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | COL6A1 MYH2 COLEC11 COL6A2 COL5A3 COLEC10 TRANK1 COL15A1 COL16A1 AHNAK | 1.36e-06 | 783 | 40 | 10 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.85e-06 | 243 | 40 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.56e-06 | 141 | 40 | 5 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 9.05e-06 | 70 | 40 | 4 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 2.25e-05 | 88 | 40 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 3.04e-05 | 95 | 40 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | 8.13e-05 | 388 | 40 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.76e-04 | 281 | 40 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.76e-04 | 281 | 40 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 2.38e-04 | 64 | 40 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 2.98e-04 | 69 | 40 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 3.24e-04 | 71 | 40 | 3 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 3.38e-04 | 72 | 40 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 3.66e-04 | 74 | 40 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 4.11e-04 | 77 | 40 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.96e-04 | 196 | 40 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | 5.34e-04 | 772 | 40 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | 5.43e-04 | 774 | 40 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.09e-04 | 207 | 40 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_100 | 6.29e-04 | 89 | 40 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.31e-04 | 371 | 40 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 6.46e-04 | 797 | 40 | 7 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 6.92e-04 | 92 | 40 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.02e-04 | 215 | 40 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 7.37e-04 | 94 | 40 | 3 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 7.72e-04 | 388 | 40 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 8.08e-04 | 97 | 40 | 3 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#5_top-relative-expression-ranked_500 | 9.30e-04 | 24 | 40 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#5 | 9.61e-04 | 103 | 40 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.07e-03 | 107 | 40 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.07e-03 | 241 | 40 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.12e-03 | 244 | 40 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.15e-03 | 424 | 40 | 5 | geo_heart_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 1.18e-03 | 27 | 40 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 1.21e-03 | 249 | 40 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.25e-03 | 251 | 40 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.80e-10 | 168 | 41 | 7 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-10 | 180 | 41 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-10 | 180 | 41 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-10 | 183 | 41 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-10 | 183 | 41 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-10 | 183 | 41 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.96e-10 | 188 | 41 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.30e-10 | 196 | 41 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-10 | 198 | 41 | 7 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-10 | 198 | 41 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-10 | 198 | 41 | 7 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.19e-09 | 159 | 41 | 6 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-08 | 169 | 41 | 6 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-08 | 170 | 41 | 6 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-08 | 177 | 41 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-08 | 180 | 41 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-08 | 181 | 41 | 6 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-08 | 181 | 41 | 6 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-08 | 181 | 41 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-08 | 181 | 41 | 6 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-08 | 182 | 41 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-08 | 184 | 41 | 6 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-08 | 185 | 41 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-08 | 185 | 41 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.78e-08 | 185 | 41 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-08 | 185 | 41 | 6 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-08 | 186 | 41 | 6 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-08 | 188 | 41 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-08 | 188 | 41 | 6 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 2.02e-08 | 189 | 41 | 6 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.02e-08 | 189 | 41 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.08e-08 | 190 | 41 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-08 | 191 | 41 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-08 | 191 | 41 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.15e-08 | 191 | 41 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 192 | 41 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 192 | 41 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-08 | 192 | 41 | 6 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.22e-08 | 192 | 41 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 192 | 41 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-08 | 192 | 41 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-08 | 192 | 41 | 6 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.29e-08 | 193 | 41 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-08 | 193 | 41 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-08 | 195 | 41 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-08 | 195 | 41 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 2.43e-08 | 195 | 41 | 6 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-08 | 195 | 41 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 2.43e-08 | 195 | 41 | 6 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-08 | 196 | 41 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.51e-08 | 196 | 41 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.58e-08 | 197 | 41 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-08 | 197 | 41 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-08 | 198 | 41 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-08 | 198 | 41 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-08 | 198 | 41 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-08 | 198 | 41 | 6 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-08 | 198 | 41 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.66e-08 | 198 | 41 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-08 | 199 | 41 | 6 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-08 | 199 | 41 | 6 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-08 | 199 | 41 | 6 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-08 | 199 | 41 | 6 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-08 | 200 | 41 | 6 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-08 | 200 | 41 | 6 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-08 | 200 | 41 | 6 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-08 | 200 | 41 | 6 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-08 | 200 | 41 | 6 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-08 | 200 | 41 | 6 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-08 | 200 | 41 | 6 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.83e-08 | 200 | 41 | 6 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.10e-07 | 126 | 41 | 5 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.10e-07 | 126 | 41 | 5 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.10e-07 | 126 | 41 | 5 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.10e-07 | 126 | 41 | 5 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.10e-07 | 126 | 41 | 5 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-07 | 134 | 41 | 5 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-07 | 153 | 41 | 5 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-07 | 153 | 41 | 5 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.89e-07 | 153 | 41 | 5 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-07 | 155 | 41 | 5 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-07 | 155 | 41 | 5 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 4.73e-07 | 169 | 41 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.02e-07 | 171 | 41 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 5.02e-07 | 171 | 41 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-07 | 171 | 41 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.31e-07 | 173 | 41 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.62e-07 | 175 | 41 | 5 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.12e-07 | 178 | 41 | 5 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.29e-07 | 179 | 41 | 5 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-07 | 180 | 41 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.46e-07 | 180 | 41 | 5 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-07 | 181 | 41 | 5 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.64e-07 | 181 | 41 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.83e-07 | 182 | 41 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-07 | 182 | 41 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.83e-07 | 182 | 41 | 5 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-07 | 182 | 41 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-07 | 182 | 41 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.83e-07 | 182 | 41 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| Computational | Adhesion molecules. | 1.36e-06 | 141 | 28 | 6 | MODULE_122 | |
| Computational | ECM and collagens. | 2.55e-04 | 225 | 28 | 5 | MODULE_47 | |
| Computational | Spinal cord (neuro-development) genes. | 2.73e-04 | 360 | 28 | 6 | MODULE_12 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.86e-04 | 50 | 28 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.86e-04 | 50 | 28 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Ovary genes. | 3.07e-04 | 368 | 28 | 6 | MODULE_1 | |
| Computational | Adrenal gland - metabolic genes. | 1.16e-03 | 314 | 28 | 5 | MODULE_19 | |
| Computational | Thymus genes. | 1.36e-03 | 325 | 28 | 5 | MODULE_44 | |
| Computational | Genes in the cancer module 156. | 1.46e-03 | 22 | 28 | 2 | MODULE_156 | |
| Computational | Neighborhood of CDH11 | 1.89e-03 | 25 | 28 | 2 | GNF2_CDH11 | |
| Computational | Neighborhood of TTN | 2.05e-03 | 26 | 28 | 2 | GNF2_TTN | |
| Drug | GK-101 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 7.05e-18 | 36 | 41 | 9 | CID000161853 |
| Drug | AC1LAKND | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 1.10e-17 | 62 | 41 | 10 | CID000470146 |
| Drug | candesartan cilexetil | COL4A1 COL4A3 COL6A1 MYH1 MYH2 COL6A2 MYH4 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 1.89e-17 | 145 | 41 | 12 | CID000002540 |
| Drug | BAPN | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.66e-17 | 71 | 41 | 10 | CID000001647 |
| Drug | hydroxylysine | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 SFTPD | 5.05e-17 | 109 | 41 | 11 | CID000001029 |
| Drug | Madecassol | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 8.14e-17 | 46 | 41 | 9 | CID000108062 |
| Drug | d-indobufen | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 1.84e-16 | 50 | 41 | 9 | CID000044562 |
| Drug | ridogrel | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 2.70e-16 | 52 | 41 | 9 | CID005362391 |
| Drug | halofuginone lactate | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 3.10e-16 | 85 | 41 | 10 | CID000062891 |
| Drug | NSC49633 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 3.25e-16 | 53 | 41 | 9 | CID000023340 |
| Drug | 4-hydroxyproline | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 6.33e-16 | 91 | 41 | 10 | CID000000825 |
| Drug | ticlopidine | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 2.29e-15 | 103 | 41 | 10 | CID000005472 |
| Drug | malotilate | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 5.33e-15 | 71 | 41 | 9 | CID000004006 |
| Drug | Tranilast sodium | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 7.13e-15 | 115 | 41 | 10 | CID000005527 |
| Drug | AC1NMZ1B | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 8.95e-15 | 75 | 41 | 9 | CID005034185 |
| Drug | strontium ranelate | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 1.15e-14 | 77 | 41 | 9 | CID006918182 |
| Drug | Selara | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 FOXG1 | 1.67e-14 | 125 | 41 | 10 | CID000150310 |
| Drug | DMSe | COL4A1 COL4A3 COL6A1 COL6A2 COL5A3 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 2.92e-14 | 132 | 41 | 10 | CID000020796 |
| Drug | pirfenidone | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.59e-14 | 138 | 41 | 10 | CID000040632 |
| Drug | DL-penicillamine | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.94e-14 | 139 | 41 | 10 | CID000004727 |
| Drug | PCR 4099 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.94e-14 | 139 | 41 | 10 | CID000002806 |
| Drug | AC1L1C2F | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 3.16e-13 | 110 | 41 | 9 | CID000001711 |
| Drug | khellin | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.02e-13 | 171 | 41 | 10 | CID000003828 |
| Drug | PPACK | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 4.05e-13 | 113 | 41 | 9 | CID003036757 |
| Drug | AC1L9732 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 4.39e-13 | 114 | 41 | 9 | CID000439300 |
| Drug | AC1L1DD6 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 6.36e-13 | 179 | 41 | 10 | CID000002299 |
| Drug | L-3,4-dehydroproline | COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 6.60e-13 | 73 | 41 | 8 | CID000094284 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 SFTPD | 6.30e-12 | 314 | 41 | 11 | CID000447989 |
| Drug | AC1Q6PCP | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 7.76e-12 | 230 | 41 | 10 | CID000005267 |
| Drug | AC1L18QD | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 FOXG1 | 9.14e-12 | 325 | 41 | 11 | CID000000213 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 1.08e-11 | 162 | 41 | 9 | CID000072363 |
| Drug | hyaluronan | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 2.92e-11 | 263 | 41 | 10 | CID000024759 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 4.31e-11 | 189 | 41 | 9 | CID000001413 |
| Drug | foscarnet | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 4.52e-11 | 190 | 41 | 9 | CID000003414 |
| Drug | silibinin | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 6.42e-11 | 285 | 41 | 10 | CID000005213 |
| Drug | chondroitin sulfate | COL4A1 COL4A3 COL6A1 NCAM1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 1.19e-10 | 413 | 41 | 11 | CID000024766 |
| Drug | prostacyclin sodium salt | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 5.18e-10 | 250 | 41 | 9 | CID000000159 |
| Drug | AC1L1KMJ | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 MARCO | 5.34e-10 | 476 | 41 | 11 | CID000030956 |
| Drug | losartan | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 1.00e-09 | 378 | 41 | 10 | CID000003961 |
| Drug | colchine | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 1.14e-09 | 383 | 41 | 10 | CID000002833 |
| Drug | Y-27632 | COL4A1 COL4A3 COL6A1 MYH2 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 4.70e-09 | 444 | 41 | 10 | CID000005711 |
| Drug | aspirin | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 4.44e-08 | 563 | 41 | 10 | CID000002244 |
| Drug | LS-63783 | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 COL19A1 | 1.18e-06 | 804 | 41 | 10 | CID000000231 |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 1.28e-06 | 195 | 41 | 6 | 2538_UP | |
| Drug | LMWH | COL4A1 COL4A3 COL6A1 COL6A2 COL7A1 COL22A1 COL13A1 COL16A1 COL25A1 | 2.17e-06 | 663 | 41 | 9 | CID000000772 |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 2734_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 3192_UP | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 2568_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 6363_DN | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 4179_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 3606_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 6700_UP | |
| Drug | alpha-methyl-D-mannoside | 5.60e-05 | 116 | 41 | 4 | CID000002108 | |
| Drug | fast white | 5.93e-05 | 42 | 41 | 3 | CID000024008 | |
| Drug | gamma-cyhalothrin | 8.32e-05 | 47 | 41 | 3 | CID000443046 | |
| Drug | pyrachlostrobin | 8.42e-05 | 811 | 41 | 8 | ctd:C513428 | |
| Drug | 2,3-pentanedione | 8.47e-05 | 129 | 41 | 4 | ctd:C013186 | |
| Drug | Pcme | 8.80e-05 | 8 | 41 | 2 | CID000169849 | |
| Drug | nifedipine | 9.27e-05 | 415 | 41 | 6 | CID000004485 | |
| Drug | formycin triphosphate | 1.06e-04 | 51 | 41 | 3 | CID000122274 | |
| Drug | sodium chloride | 1.32e-04 | 865 | 41 | 8 | CID000000206 | |
| Drug | chrysene | 1.38e-04 | 871 | 41 | 8 | ctd:C031180 | |
| Drug | AC1NFC6P | 1.44e-04 | 148 | 41 | 4 | CID000004587 | |
| Drug | purealin | 1.56e-04 | 58 | 41 | 3 | CID006419303 | |
| Drug | Spermine | 2.00e-04 | 63 | 41 | 3 | ctd:D013096 | |
| Drug | 4-aminoazobenzene | 2.29e-04 | 66 | 41 | 3 | CID000006051 | |
| Drug | 2f1b | 2.40e-04 | 67 | 41 | 3 | CID011963508 | |
| Drug | AC1L1IIA | 2.56e-04 | 172 | 41 | 4 | CID000004591 | |
| Drug | Botulinum Toxins, Type A | 3.74e-04 | 16 | 41 | 2 | ctd:D019274 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 3114_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; HL60; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 2509_UP | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3816_UP | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3988_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; HL60; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 2160_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 5813_UP | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 4172_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 4.12e-04 | 195 | 41 | 4 | 1732_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 3028_UP | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3998_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 1515_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3400_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4567_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; HL60; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2726_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2735_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4461_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2306_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4154_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3085_UP | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 6817_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 4355_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5641_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3484_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5887_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 6138_UP | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5435_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3471_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2204_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2253_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 1514_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3168_UP | |
| Disease | myopathy (implicated_via_orthology) | 5.77e-11 | 48 | 41 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.97e-07 | 10 | 41 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 5.43e-07 | 12 | 41 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.43e-07 | 12 | 41 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.05e-07 | 13 | 41 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.12e-06 | 15 | 41 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.91e-06 | 71 | 41 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Malpuech facial clefting syndrome | 5.65e-06 | 3 | 41 | 2 | C0796032 | |
| Disease | Craniofacial ulnar renal syndrome | 5.65e-06 | 3 | 41 | 2 | C4303860 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.13e-05 | 4 | 41 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 1.13e-05 | 4 | 41 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.13e-05 | 4 | 41 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.13e-05 | 4 | 41 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.13e-05 | 4 | 41 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | MRNA-decapping enzyme 1A measurement | 1.13e-05 | 4 | 41 | 2 | EFO_0802757 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.13e-05 | 4 | 41 | 2 | C0410179 | |
| Disease | collectin-11 measurement | 1.88e-05 | 5 | 41 | 2 | EFO_0008088 | |
| Disease | collectin-10 measurement | 6.74e-05 | 9 | 41 | 2 | EFO_0801491 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.23e-04 | 12 | 41 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | collagen disease (implicated_via_orthology) | 1.23e-04 | 12 | 41 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.90e-04 | 80 | 41 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | 2.40e-04 | 914 | 41 | 7 | EFO_0004532 | |
| Disease | waist-hip ratio | 2.44e-04 | 1226 | 41 | 8 | EFO_0004343 | |
| Disease | Early Pregnancy Loss | 4.72e-04 | 109 | 41 | 3 | C3830362 | |
| Disease | Miscarriage | 4.72e-04 | 109 | 41 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 4.72e-04 | 109 | 41 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 4.72e-04 | 109 | 41 | 3 | C0000822 | |
| Disease | Myasthenic Syndromes, Congenital | 5.10e-04 | 24 | 41 | 2 | C0751882 | |
| Disease | spine bone mineral density | 6.10e-04 | 119 | 41 | 3 | EFO_0007701 | |
| Disease | intraocular pressure measurement | 6.72e-04 | 509 | 41 | 5 | EFO_0004695 | |
| Disease | skin pigmentation measurement | 9.17e-04 | 137 | 41 | 3 | EFO_0007009 | |
| Disease | Heart Failure, Diastolic | 9.68e-04 | 33 | 41 | 2 | C1135196 | |
| Disease | Growth Disorders | 1.15e-03 | 36 | 41 | 2 | C0018273 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDKKTKEGKGGEGKR | 541 | F5H4B4 | |
| DLKGEKGDKGAMGEP | 256 | Q01955 | |
| GEKGQKGEKGDGGIK | 396 | Q07092 | |
| KGEKGDGGIKGVPGK | 401 | Q07092 | |
| GGKPGKPGVKGEKGD | 491 | Q07092 | |
| GSEGKPCGELKKEKG | 61 | Q14833 | |
| LKGPKIKGGADVSGG | 5561 | Q09666 | |
| GNIGKTGPIGKKGDK | 86 | Q9Y6Z7 | |
| TGPIGKKGDKGEKGL | 91 | Q9Y6Z7 | |
| KKGDKGEKGLLGIPG | 96 | Q9Y6Z7 | |
| GEKGLLGIPGEKGKA | 101 | Q9Y6Z7 | |
| KKGDKAPGGGGANLK | 51 | P23582 | |
| KPENEKKGDGGALGG | 11 | Q9BXU9 | |
| RGKPGKDGDKGEKGS | 286 | P02462 | |
| NSGGGGKKPKMEELG | 1491 | Q7Z5J4 | |
| KANPDGKKKGDGGGA | 216 | Q9UKM9 | |
| GSRGEKGDLGPKGEK | 186 | Q9Y215 | |
| KGETGGAREPKGEKG | 181 | Q9NTI7 | |
| KEGGDGAAGDPKKEK | 41 | Q13442 | |
| KKGAGEGGKDGEGGK | 156 | P55316 | |
| EGGKDGEGGKEGEKK | 161 | P55316 | |
| EGEGAGGGAKKGGKK | 631 | Q9UKX2 | |
| GPRGEKGDLGEKGEK | 601 | Q9BXS0 | |
| GKKGEDGKGNGEDGK | 176 | P82970 | |
| DGAKKAVGGLGKLGK | 71 | P81605 | |
| EAEAGGGKKGGKKKG | 631 | P12882 | |
| GLKWGGTHDGPKKKG | 51 | Q86Y91 | |
| GAKGEKGDKGDLGPR | 81 | Q9BXJ4 | |
| KGDKGERGECGKPGI | 291 | Q2UY09 | |
| ERGECGKPGIKGDKG | 296 | Q2UY09 | |
| KGDPGAFGLKGEKGE | 361 | P12109 | |
| GEHGIPGKQGIKGEK | 546 | Q14993 | |
| DFGLKGEPGRKGEKG | 541 | P12110 | |
| GLKGDAGEKGDKGAP | 41 | Q9BWP8 | |
| FKGERGDPGIKGDKG | 1391 | Q8NFW1 | |
| GEKGSKGDGGLIGPK | 226 | Q9UEW3 | |
| KGEKGDLGLPGSKGD | 246 | Q9UEW3 | |
| PGKKGEKGDSEDGAP | 1441 | Q02388 | |
| GPKGEAGLDGAKGEK | 586 | Q5TAT6 | |
| GERGKKGSRGPKGDK | 676 | Q5TAT6 | |
| KGEKGDRGPKGERGM | 766 | P39059 | |
| LKGENGDKGFKGEKG | 1026 | P39059 | |
| GDKGFKGEKGEKGDI | 1031 | P39059 | |
| EKGEKGEDGFPGFKG | 726 | P25940 | |
| GGPGAKGEKGEMGEK | 221 | A6NHN0 | |
| GGKGQKGEGGMKGEK | 251 | A6NHN0 | |
| KGEGGMKGEKGSKGD | 256 | A6NHN0 | |
| EAEGGGGKKGGKKKG | 631 | Q9Y623 | |
| KETPGGGGDAGKKRK | 116 | O95096 | |
| GKAGPGAKGKDMEEG | 761 | P13591 | |
| DKGIPGDKGAKGESG | 206 | P35247 | |
| GPGGLVAGKEEKKKA | 16 | A6NIH7 | |
| GKEGKKDDKPTLGAG | 721 | O15050 | |
| KKGEAEGPGGKEKGL | 4831 | O14686 |